Blog
RSS FeedPosted by Michael Wonder on 07 Dec 2017
ALK secures pricing and reimbursement for Acarizax in France
30 November 2017 - ALK today announced that it has reached a satisfactory agreement with health authorities in France for ...
Posted by Michael Wonder on 05 Dec 2017
Agenda for 6 December TC meeting
4 December 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 24 Nov 2017
Agenda for 22 November TC meeting
22 November 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 10 Nov 2017
Agenda for 9 November TC meeting
7 November 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 21 Oct 2017
Agenda for 25 October TC meeting
20 October 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 10 Oct 2017
Agenda for 11 October TC meeting
9 October 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 26 Sep 2017
Agenda for 27 September TC meeting
25 September 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 11 Sep 2017
Agenda for 13 September TC meeting
8 September 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 15 Jul 2017
Agenda for 19 July TC meeting
15 July 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 06 Jul 2017
HAS publishes TC opinion on Olumiant
6 July 2017 - The medical service rendered by Olumiant (baricitinib) is important. ...
Posted by Michael Wonder on 21 Jun 2017
Transparency Commission publishes opinion for Keytruda
20 June 2017 - The opinion relates to the use of pembrolizumab for the first-line use in patients with non-small-cell ...
Posted by Michael Wonder on 18 Jun 2017
Agenda for 21 June TC meeting
16 June 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 04 Jun 2017
Agenda for 7 June 2017 TC meeting
2 June 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 02 Jun 2017
Transparency Commission revises ASMR for Imbruvica
1 June 2017 - The Transparency Commission has published its revised opinion on the ASMR for ibrutinib for patients with ...
Posted by Michael Wonder on 25 May 2017
Transparency Commission publishes its review of Keytruda's SMR & ASMR
22 May 2017 - The Transparency Commission has reviewed its SMR & ASMR ratings of pembrolizumab for malignant melanoma. ...